Suicidality among users of glucagon-like peptide-1 receptor agonists: an emerging signal
Safety concerns : Important risks associated with GLP-1 receptor agonists include pancreatitis, gallbladder disease, dehydration leading to acute kidney injury, hypoglycaemia (when used with insulin or sulfonylureas), and potential worsening of diabetic retinopathy with rapid glycaemic improvement
Consensus molecular subtypes (CMS), markers of systemic inflammation (SI) and clinicopathological parameters in colorectal cancer (CRC)
Pioglitazone in early Parkinsons disease: a phase 2, multicentre, double-blind, randomised trial
Epidemiology and genetics of rheumatoid arthritis
100% stimulant-free no caffeine, no jitters making it stackable with any thermogenic, pre-workout, or standalone for anyone avoiding stimulants